Which of the following statements is not correct regarding male breast cancer?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Male Breast Cancer Characteristics: Identifying the Incorrect Statement

The statement "Most commonly it is infiltrating lobular carcinoma" is not correct regarding male breast cancer.

Male breast cancer has several distinct characteristics that differentiate it from female breast cancer. Let's examine each statement:

Epidemiology and Prevalence

  • Male breast cancer accounts for less than 1% of all breast cancers, not 2% as stated in option A 1, 2
  • Male breast cancer is a rare malignancy, representing approximately 0.8% of all breast cancer cases 3

Risk Factors

  • Exocrine or endocrine estrogen exposure can indeed predispose men to breast cancer 4, 5
  • Conditions associated with hyperestrogenism, such as Klinefelter's syndrome, are established risk factors for male breast cancer 5
  • Other risk factors include genetic predisposition (particularly BRCA2 mutations), radiation exposure to the chest, and testicular disease 4, 5, 3

Histological Types

  • Invasive ductal carcinoma is the predominant histological type in male breast cancer, accounting for approximately 90% of cases 6
  • Infiltrating lobular carcinoma is extremely rare in men, representing less than 1% of all male breast cancers 7
  • The rarity of infiltrating lobular carcinoma in men is attributed to the limited development of lobular elements in the male breast 1

Clinical Presentation

  • Male breast cancer typically presents as a painless, firm subareolar mass or a mass in the upper outer quadrant of the breast 8
  • On imaging, male breast cancer typically appears as an irregular mass, often without calcifications and eccentric to the nipple 2

Treatment Considerations

  • Male breast cancer is predominantly hormone receptor-positive (81% estrogen receptor positive, 74% progesterone receptor positive) 3
  • Tamoxifen is the standard adjuvant therapy for hormone receptor-positive male breast cancer 5
  • Treatment approaches are similar to those for women but must account for the higher prevalence of hormone receptor positivity in men 1

The histological pattern of male breast cancer is a critical distinguishing feature, with invasive ductal carcinoma being the predominant type, not infiltrating lobular carcinoma as incorrectly stated in option D.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

From the radiologic pathology archives: diseases of the male breast: radiologic-pathologic correlation.

Radiographics : a review publication of the Radiological Society of North America, Inc, 2013

Research

Breast cancer in men.

Annals of internal medicine, 2002

Guideline

Male Breast Cancer Characteristics and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Male Breast Cancer Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Invasive lobular carcinoma of the male breast: A rare histology of an uncommon disease.

Journal of the Egyptian National Cancer Institute, 2016

Research

Carcinoma of the male breast.

Annals of internal medicine, 1992

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.